Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

Status Trial Number Title Sort descending Activated Closed Accrual Phase Published
Closed SWOG-8691 (INT-0073) (INT-0073), A Randomized Comparison of Deoxycoformycin Versus Alpha-Interferon in Previously Untreated Patients With Hairy Cell Leukemia 12/15/1986 10/1/1991 100% Published
Closed SWOG-8917 5-Fluorouracil, Leucovorin and Roferon-A® in Advanced Colorectal Cancer, Phase II Pilot 12/1/1989 2/15/1992 100% Published
Closed SWOG-8017 5-FU, Adriamycin, Streptozotocin and Cyclophosphamide (FAC-S) in the Treatment of Metastatic Carcinoid Tumors 7/7/1980 1/19/1984 Published
Closed SWOG-425/426 6-Mercaptopurine (NSC-755) and 6-Methylmercaptopurine Riboside (NSC-40774) Combination in the Treatment of Adult Acute Leukemia 11/4/1969 9%
Closed SWOG-8210 A Comparison of Aggressive Radiotherapy Plus Chemo- therapy Versus Aggressive Chemotherapy in the Treatment of Limited Carcinoma of the Pancreas 9/17/1982 3/16/1984
Closed SWOG-8894 (INT-0105) (EST-2889) A Comparison of Bilateral Orchiectomy with or without Flutamide for the Treatment of Patients with Histologically Confirmed Stage D2 Prostate Cancer 12/15/1989 9/15/1994 100% Published
Closed SWOG-7814 A Comparison of Methotrexate and Cis-Platinum for Patients with Advanced Squamous Cell Carcinoma of the Head and Neck Region 6/8/1978 10/16/1979 Published
Closed SWOG-7519 A Comparison of Methotrexate with a Three-Drug Combination, Methotrexate, Methyl-CCNU & Bleomycin for Patients with Advanced Squamous Cell Carcinoma of the Head and Neck Region 10/17/1975 3/1/1978
Closed SWOG-9126 A Controlled Trial of Cyclosporine as a Chemotherapy- Resistance Modifier in High Risk Acute Myeloid Leukemia, Phase III 3/1/1993 3/1/1998 100% Published
Closed SWOG-9032 A Controlled Trial of Cyclosporine As A Chemotherapy-Resistance Modifier in Blast Phase-Chronic Myelogenous Leukemia 6/1/1992 3/1/1998 100% Published
Closed SWOG-9031 A Double Blind Placebo Controlled Trial of Daunomycin and Cytosine Arabinoside With or Without rhG-CSF in Elderly Patients With Acute Myeloid Leukemia 11/15/1991 1/15/1995 100% Published
Closed S9617 A Phase I Study of PSC833 As Chemotherapy – Resistance Modifier in Patients Over Age 55 With Previously Untreated Myeloid Leukemia (AML). 11/1/1996 9/1/1998 100% Published
Closed SWOG-9112 A Phase I Study of the Combination of High Dose Chemotherapy, Granulocytemacrophage Colony Stimulating Factor, and Interleukin-2 7/15/1991 11/1/1992 3%
Closed SWOG-8940 A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer 3/1/1990 11/1/1992 100% Published
Closed SWOG-9462 (NABTC-9404) (NCI T94-0034) A Phase I Trial and Pharmacokinetic Study of the Sequential Administration of Carmustine (BCNU) and Temozolomide in Patients with CNS or Systemic Tumors Refractory to Standard Therapy 7/28/1995 8/15/1997 90%
Closed SWOG-9026 A Phase I, Open Label, Multicenter Study of the Safety, Tolerability and Biological Effects of SDZ ILE 964 (Recombinant Human Interleukin-3), Administered to Patients with Metastatic Cancer Prior to… 7/15/1991 9/29/1992 100% Published
Closed SWOG-9436 (NABTC-9403) (NCI T94-0184) A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma 4/18/1995 2/4/1998 95% Published
Closed SWOG-9006 A Phase II 19F Magnetic Resonance Spectroscopy (MRS) Study of 5-FU and Correlation with Clinical Results of 5-FU/Leucovorin (LV) Therapy in Patients with Carcinomas of the Gastrointestinal Tract 10/15/1990 11/1/1996 77% Published
Closed SWOG-9213 A Phase II Evaluation of Fazarabine for Patients with "Poor Prognosis” Extensive Stage Small Cell Lung Cancer 6/15/1993 6/15/1994 10%
Closed SWOG-9246 A Phase II Evaluation of Taxol in Patients with Relapsed Non-Hodgkin's Lymphoma 3/1/1993 12/1/1995 58% Published
Scroll Table